Literature DB >> 20000367

Triple recognition of B-DNA by a neomycin-Hoechst 33258-pyrene conjugate.

Bert Willis1, Dev P Arya.   

Abstract

Recent developments have indicated that aminoglycoside binding is not limited to RNA, but to nucleic acids that, like RNA, adopt conformations similar to its A-form. We further sought to expand the utility of aminoglycoside binding to B-DNA structures by conjugating neomycin, an aminoglycoside antibiotic, with the B-DNA minor groove binding ligand Hoechst 33258. Envisioning a dual groove binding mode, we have extended the potential recognition process to include a third, intercalative moiety. Similar conjugates, which vary in the number of binding moieties but maintain identical linkages to allow direct comparisons to be made, have also been prepared. We report herein novel neomycin- and Hoechst 33258-based conjugates developed in our laboratories for exploring the recognition potential with B-DNA. Spectroscopic studies such as UV melting, differential scanning calorimetry, isothermal fluorescence titrations, and circular dichroism together illustrate the triple recognition of the novel conjugate containing neomycin, Hoechst 33258, and pyrene. This study represents the first example of DNA molecular recognition capable of minor versus major groove recognition in conjunction with intercalation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20000367     DOI: 10.1021/bi9016796

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  27 in total

1.  Click dimers to target HIV TAR RNA conformation.

Authors:  Sunil Kumar; Patrick Kellish; W Edward Robinson; Deyun Wang; Daniel H Appella; Dev P Arya
Journal:  Biochemistry       Date:  2012-03-09       Impact factor: 3.162

2.  Recognition of HIV-TAR RNA using neomycin-benzimidazole conjugates.

Authors:  Nihar Ranjan; Sunil Kumar; Derrick Watkins; Deyun Wang; Daniel H Appella; Dev P Arya
Journal:  Bioorg Med Chem Lett       Date:  2013-08-14       Impact factor: 2.823

3.  Utilization of chromic polydiacetylene assemblies as a platform to probe specific binding between drug and RNA.

Authors:  Anothai Kamphan; Changjun Gong; Krishnagopal Maiti; Souvik Sur; Rakchart Traiphol; Dev P Arya
Journal:  RSC Adv       Date:  2017-08-24       Impact factor: 3.361

4.  A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2015-11-19       Impact factor: 3.597

Review 5.  Analysis of carbohydrates and glycoconjugates by matrix-assisted laser desorption/ionization mass spectrometry: an update for 2009-2010.

Authors:  David J Harvey
Journal:  Mass Spectrom Rev       Date:  2014-05-26       Impact factor: 10.946

Review 6.  Comprehensive review of chemical strategies for the preparation of new aminoglycosides and their biological activities.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Chem Soc Rev       Date:  2018-02-19       Impact factor: 54.564

7.  Linker dependent intercalation of bisbenzimidazole-aminosugars in an RNA duplex; selectivity in RNA vs. DNA binding.

Authors:  Nihar Ranjan; Dev P Arya
Journal:  Bioorg Med Chem Lett       Date:  2016-10-27       Impact factor: 2.823

8.  Aminoglycoside binding to Oxytricha nova telomeric DNA.

Authors:  Nihar Ranjan; Katrine F Andreasen; Sunil Kumar; David Hyde-Volpe; Dev P Arya
Journal:  Biochemistry       Date:  2010-10-22       Impact factor: 3.162

9.  Shape readout of AT-rich DNA by carbohydrates.

Authors:  Sunil Kumar; Meredith Newby Spano; Dev P Arya
Journal:  Biopolymers       Date:  2014-07       Impact factor: 2.505

10.  Selective Inhibition of Bacterial Topoisomerase I by alkynyl-bisbenzimidazoles.

Authors:  Nihar Ranjan; Geraldine Fulcrand; Ada King; Joseph Brown; Xiuping Jiang; Fenfei Leng; Dev P Arya
Journal:  Medchemcomm       Date:  2014-06-01       Impact factor: 3.597

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.